Human cells adapt to translational errors by modulating protein synthesis rate and protein turnover

RNA Biol. 2020 Jan;17(1):135-149. doi: 10.1080/15476286.2019.1670039. Epub 2019 Oct 1.

Abstract

Deregulation of tRNAs, aminoacyl-tRNA synthetases (aaRS) or tRNA modifying enzymes, increase the level of protein synthesis errors (PSE) and are associated with several diseases, but the cause-effect mechanisms of these pathologies remain elusive. To clarify the role of PSE in human biology, we have engineered a HEK293 cell line to overexpress a wild type (Wt) tRNASer and two tRNASer mutants that misincorporate serine at non-cognate codon sites. Then, we followed long-term adaptation to PSE of such recombinant cells by analysing cell viability, protein synthesis rate and activation of protein quality control mechanisms (PQC). Engineered cells showed higher level of misfolded and aggregated proteins; activated the ubiquitin-proteasome system (UPS) and the unfolded protein response (UPR), indicative of proteotoxic stress. Adaptation to PSE involved increased protein turnover, UPR up-regulation and altered protein synthesis rate. Gene expression analysis showed that engineered cells presented recurrent alterations in the endoplasmic reticulum, cell adhesion and calcium homeostasis. Herein, we unveil new phenotypic consequences of protein synthesis errors in human cells and identify the protein quality control processes that are necessary for long-term adaptation to PSE and proteotoxic stress. Our data provide important insight on how chronic proteotoxic stress may cause disease and highlight potential biological pathways that support the association of PSE with disease.

Keywords: Protein synthesis errors; human cells; protein quality control; tRNAs; ubiquitin-proteasome system; unfolded protein response.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adaptation, Biological*
  • Computational Biology / methods
  • Gene Expression Regulation*
  • Gene Ontology
  • HEK293 Cells
  • Humans
  • Molecular Chaperones / metabolism
  • Mutation*
  • Proteasome Endopeptidase Complex
  • Protein Biosynthesis*
  • Protein Processing, Post-Translational
  • RNA, Transfer / genetics
  • Ubiquitin / metabolism
  • Unfolded Protein Response

Substances

  • Molecular Chaperones
  • Ubiquitin
  • RNA, Transfer
  • Proteasome Endopeptidase Complex

Grants and funding

Ipatimup integrates the i3S Research Unit. iBiMED and i3SResearch Units are partially supported by the Portuguese Foundation for Science and Technology (Fundação para a Ciência e a Tecnologia-FCT). This research was founded by 1) FEDER – Fundo Europeu de Desenvolvimento Regional funds through the COMPETE 2020 –- Operational Programme for Competitiveness and Internationalization (POCI), Portugal 2020, and by Portuguese funds through FCT –- Foundation for Science and Technology/Ministério da Ciência, Tecnologia e Inovação in the framework of the projects: ‘Institute for Research and Innovation in Health Sciences’(POCI-01-0145-FEDER-007274), and ‘PEst-C/SAU/LA0003/2013’; 2) NORTE-01-0145-FEDER-000029, supported by Norte Portugal Regional Programme (NORTE 2020), under the PORTUGAL 2020 Partnership Agreement, through the European Regional Development Fund (ERDF); 3) The Aveiro Institute of Biomedicine – iBiMED is supported by FCT grant UID/BIM/04501/2013, the Ilídio Pinho Foundation and the University of Aveiro, POCI-01-0145-FEDER-007628, and through European and Structural funds (CENTRO2020) provided by CCDR through project PAGE: CENTRO-01-0145-FEDER-000003. The funders had no role in study design, data collection, and analysis, decision to publish, or preparation of the manuscript; Fundação para a Ciência e a Tecnologia [POCI-01-0145-FEDER-016428]; Fundação para a Ciência e a Tecnologia [SFRH/BD/91020/2012]; Fundação para a Ciência e a Tecnologia [SFRH/BD/76417/2011]; Fundação para a Ciência e a Tecnologia [POCI-01-0145-FEDER-028834]; Fundação para a Ciência e a Tecnologia [PTDC/BiA-MiB/31238/2017]; Fundação para a Ciência e a Tecnologia [PEst-C/SAU/LA0003/2013]; Fundação para a Ciência e a Tecnologia [PTDC/BIM-MEC/1719/2014]; Fundação para a Ciência e a Tecnologia [PTDC/BEX-BCM/2121/2014]; Fundação para a Ciência e a Tecnologia [UID/BIM/04501/2013]; FEDER [POCI-01-0145-FEDER-007628]; Fundo Europeu de Desenvolvimento Regional [NORTE-01-0145-FEDER-000029]; FEDER [POCI-01-0145-FEDER-007274]; CENTRO2020 [CENTRO-01-0145-FEDER-000003].